
Financial Performance - Q1 2025 revenue increased by 6.2% year-over-year, from $26 million to $27.6 million[19] - Net income turned around from a loss of $0.24 million in Q1 2024 to a profit of $1.95 million in Q1 2025[19] - Free cash flow increased by 63.6% from $2.2 million in Q1 2024 to $3.6 million in Q1 2025[21] - Adjusted EBITDA increased by 63.6% from $3.6 million in Q1 2024 to $5.6 million in Q1 2025[41] - Adjusted net income increased by 941% from $0.2 million in Q1 2024 to $2.3 million in Q1 2025[41] Strategic Initiatives - The company is focusing on AI-driven solutions to transform healthcare[1,26] - The company launched an AI Center of Excellence in Bagh, targeting 500 AI professionals by year-end[28,29] - The company is expanding its specialty EHR portfolio with a focus on GI and Dermatology[35,36] - The company completed acquisitions of MesaBilling LLC and RevNu Medical Management in early 2025 to enhance client base and expand reach into underserved specialty markets[24] Capital Structure - Post-conversion capital structure shows common equity at 62% and preferred equity at 38%[21] - Pre-conversion capital structure shows common equity at 31% and preferred equity at 69%[21]